Sebi cancels Basan Financial Services licence over regulatory violations

Sebi cancels Basan Financial Services licence over regulatory violations



The Securities and Exchange Board of India (Sebi) has cancelled the merchant banking licence of Basan Financial Services, citing a series of regulatory violations and persistent non-compliance with key norms. In a final order issued on April 7, the regulator found that the Hyderabad-based entity had failed to meet several critical requirements under the merchant banking and insider trading regulations during the inspection period between April 2022 and June 2023. 


Om Power Transmission IPO to open on April 9

 


Om Power Transmission’s ₹150 crore IPO will open on April 9 and close on April 13. The price band for the issue has been set at ₹166-175 per share. The issue comprises of ₹133 crore fresh share sale and ₹18 crore offer for sale. At the top-end of the price band, the company is valued at nearly ₹600 crore. Om Power is an EPC contractor for the power distribution sector. 

 


InCred Special Opportunities Fund-I announces final close

 


InCred Capital’s alternatives asset platform InCred Alternative Private Investments on Tuesday announced final close of its maiden special opportunities credit fund at ₹1,500 crore. InCred Special Opportunities Fund – I attracted commitments from domestic family offices, ultra HNIs, and international investors. Nearly 75 per cent of the fund has already been deployed across sectors such as auto, power, oil & gas, and hospitality. The firm stated that with the raise, InCred Alternatives has successfully raised over ₹4,000 crore across its performing credit funds and special situation funds.

First Published: Apr 07 2026 | 11:15 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets


Aurobindo Pharma announced that the final approval is received from the US Food & Drug Administration (USFDA) to manufacture and market Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, 5 mg/ 500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xigduo XR Tablets, 5 mg/ 500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg, of AstraZeneca AB. These products will be manufactured at Unit-IV of APL Healthcare, a wholly owned subsidiary of the Company and will be launched immediately.
 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 07 2026 | 8:31 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

CLEANMAX commissions 185 MW hybrid renewable energy project at Kalavad, Gujarat


Clean Max Enviro Energy Solutions announced the commissioning of its 185 MW hybrid renewable energy project at Kalavad, Gujarat.

The project supports the company’s rapidly expanding clean energy portfolio in the state. Comprising integrated solar and wind capacity, the project has been developed over ~12 months, supplying green energy to 17 distinct corporate customers.

Kalavad adds to CleanMax’s hybrid build-out in Gujarat, improving its ability to deliver more consistent renewable supply for round-the-clock industrial demand. This takes its total operational capacity in the state of Gujarat currently to ~844 MW as of 31 March 2026.

The project supplies renewable power to 17 corporate customers under the group captive model, wherein customers invest equity in the project complying with captive rules under the Electricity act, while securing long-term access to clean energy. Publicly listed companies like Apar Industries, Borosil Renewables, are among the customers of this project.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 07 2026 | 8:16 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

Biocon launches biosimilars – Bosaya and Aukelso in U.S.


Biocon announced the commercial launch of Bosaya (denosumab-kyqq) and Aukelso (denosumab kyqq) in the United States.

Bosaya (biosimilar to Prolia) and Aukelso (biosimilar to Xgeva) are now available by prescription nationwide through specialty pharmacies and healthcare providers.

Both products have been previously approved and granted interchangeable designation by the U.S. Food and Drug Administration in September 2025, allowing substitution at the pharmacy level in accordance with state laws.

Shreehas Tambe, CEO & Managing Director, Biocon, said, The U.S. introduction of Bosaya and Aukelso marks a strategic expansion of our biosimilars portfolio, building on our established leadership in oncology and immunology. These therapies broaden access to high-quality, affordable treatment options for patients living with serious bone conditions. This milestone underscores Biocon’s strength as a portfolio development engine and our focus on building the world’s most scalable access platformadvancing life-changing medicines for patients and health systems across the United States and around the world.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 07 2026 | 8:04 PM IST



Source link

Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

EFC (I) achieves 90% occupancy for its premium Grade-A office infra at Wakadewadi, Pune


EFC (I) announced a significant operational milestone that Sprint Business Center, Wakadewadi, Pune, a fully owned asset of the company spread over 49,556 sq., has now been successfully developed as a premium A-Grade commercial workspace and has achieved over 90% occupancy in record time.

This landmark achievement reflects the strong demand for high-quality, managed office spaces in Pune’s commercial real estate market and reinforces EFC’s robust execution capabilities. The property has been leased out to large enterprise and multinational clients, further strengthening the company’s premium tenant portfolio.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 07 2026 | 8:04 PM IST



Source link

YouTube
Instagram
WhatsApp